193 related articles for article (PubMed ID: 17687057)
1. Emerging pharmacotherapies for smoking cessation.
Garwood CL; Potts LA
Am J Health Syst Pharm; 2007 Aug; 64(16):1693-8. PubMed ID: 17687057
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing weight gain after smoking cessation.
Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
[TBL] [Abstract][Full Text] [Related]
3. [Current and future medical drugs for smoking cessation].
Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
[TBL] [Abstract][Full Text] [Related]
4. Non-nicotinic therapies for smoking cessation.
Siu EC; Tyndale RF
Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor 5 as a potential target for smoking cessation.
Chiamulera C; Marzo CM; Balfour DJK
Psychopharmacology (Berl); 2017 May; 234(9-10):1357-1370. PubMed ID: 27847973
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacological treatments for nicotine dependence.
George TP; O'Malley SS
Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978
[TBL] [Abstract][Full Text] [Related]
7. Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking.
Gómez-Coronado N; Walker AJ; Berk M; Dodd S
Pharmacotherapy; 2018 Feb; 38(2):235-258. PubMed ID: 29250815
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic receptor-based therapeutics and candidates for smoking cessation.
Dwoskin LP; Smith AM; Wooters TE; Zhang Z; Crooks PA; Bardo MT
Biochem Pharmacol; 2009 Oct; 78(7):732-43. PubMed ID: 19523455
[TBL] [Abstract][Full Text] [Related]
9. Smoking cessation: lessons learned from clinical trial evidence.
Reid RD; Quinlan B; Riley DL; Pipe AL
Curr Opin Cardiol; 2007 Jul; 22(4):280-5. PubMed ID: 17556878
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
Rigotti NA; Gonzales D; Dale LC; Lawrence D; Chang Y;
Addiction; 2009 Feb; 104(2):266-76. PubMed ID: 19149823
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacology and potential efficacy of new treatments for tobacco dependence.
Fagerström K; Balfour DJ
Expert Opin Investig Drugs; 2006 Feb; 15(2):107-16. PubMed ID: 16433591
[TBL] [Abstract][Full Text] [Related]
12. Neuroscience of nicotine for addiction medicine: novel targets for smoking cessation medications.
D'Souza MS
Prog Brain Res; 2016; 223():191-214. PubMed ID: 26806777
[TBL] [Abstract][Full Text] [Related]
13. Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
Baraona LK; Lovelace D; Daniels JL; McDaniel L
J Midwifery Womens Health; 2017 May; 62(3):253-269. PubMed ID: 28556464
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of varenicline for smoking cessation.
Hays JT; Ebbert JO; Sood A
Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
[TBL] [Abstract][Full Text] [Related]
15. Update on pharmacologic options for smoking cessation treatment.
Nides M
Am J Med; 2008 Apr; 121(4 Suppl 1):S20-31. PubMed ID: 18342163
[TBL] [Abstract][Full Text] [Related]
16. Nicotine and non-nicotine smoking cessation pharmacotherapies.
Frishman WH; Mitta W; Kupersmith A; Ky T
Cardiol Rev; 2006; 14(2):57-73. PubMed ID: 16493243
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
Cahill K; Ussher M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005353. PubMed ID: 17636794
[TBL] [Abstract][Full Text] [Related]
18. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
[TBL] [Abstract][Full Text] [Related]
19. An update on therapeutics for tobacco dependence.
Lancaster T; Stead L; Cahill K
Expert Opin Pharmacother; 2008 Jan; 9(1):15-22. PubMed ID: 18076335
[TBL] [Abstract][Full Text] [Related]
20. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
